Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

US lawmakers pass new bill to speed up drug reviews

FDA will also need to take the views of patients into greater consideration under new plans

- PMLiVE

Afinitor set for filing this year in neuroendocrine cancer

Novartis drug is already approved for breast and renal cancers

- PMLiVE

Celgene’s psoriasis pill gives ‘no added benefit’ to patients

Germany’s cost assessor IQWiG says Otezla is not value for money

ARC names chairman and member of the board

Mark McDade and Mark Iwicki to join

How do you solve a problem like non-adherence? Part 1

Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...

Blue Latitude Health

How to design patient services with social media within the ABPI code guidelines

In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.

Blue Latitude Health

Sanofi reception

Sanofi says sarilumab filing for arthritis on track

Looks likely to be filed before the end of the year

UK ramps up online access to GP services

Number of practices offering services like appointments via the internet tripled in first three months of 2015

- PMLiVE

Baxalta will add $2.5bn in new product turnover by 2020

Pro forma sales expected to grow up to 8% between 2016 and 2020

Biogen promotes Matt Griffiths to chief information officer

He originally joined the firm from Dell earlier this year

- PMLiVE

Health Unlimited partners with digital agency Propeller Communications

Propeller will move from its New Jersey and Manhattan offices to Health Unlimited's New York base

- PMLiVE

Ipsen acquires OctreoPharm to boost its oncology presence

Will aid the development of its approach to neuroendrocrine tumours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links